Pacheco-Rosado Jorge, Arias-Citalán G, Ortiz-Butrón R, Rodríquez-Páez L
Depto. de Fisiología Mauricio Russek, Escuela Nacional de Ciencias Biológicas, I.P.N., Carpio y Plan de Ayala, México, D.F., 11340.
Proc West Pharmacol Soc. 2005;48:52-4.
The present work was performed in order to know if mild hypothyroidism in rats modifies the activity of the Na+/K+ -ATPase in different regions of the brain. Male Wistar rats (300-350 g) were randomly divided into three groups: (1) control group (n=8) drank tap water. (2) hypothyroid group (n=8) treated with 60 mg/kg of methimazole in drinking water; and (3) replaced group (n=8) treated with 60 mg/kg of methimazole plus 35 microg/kg of thyroid hormone (T3) in drinking water. After four weeks of treatment, the rats of all groups were sacrificed by decapitation. The cortex, amygdala, hippocampus and cerebellum were dissected and frozen at -70 degrees C until assay. For enzymatic assay, the tissues were homogenized. The Na+/K+ -ATPase activity was determined by quantifying inorganic phosphate after the samples were incubated with ATP in the presence and absence of 1 mM ouabain. The Na+/K+ -ATPase activity is expressed as pmoles Pi/hr/mg protein. The results showed that the Na+/K+ -ATPase activity in the cortex, amygdala and hippocampus, but not in cerebellum, was lower in hypothyroid group than in control group (p<0.05). The co-administration of methimazole and T3 avoided the decrease of Na+/K+ -ATPase activity, except in amygdala. According to the results obtained we concluded that methimazole treatment decreased the Na+/K+- ATPase activity in the brain's regions which are related to seizures onset. That decrement in enzyme activity was avoided with the coadministration of thyroid hormone.
开展本研究是为了了解大鼠轻度甲状腺功能减退是否会改变大脑不同区域钠钾ATP酶(Na+/K+ -ATPase)的活性。将雄性Wistar大鼠(体重300 - 350克)随机分为三组:(1)对照组(n = 8)饮用自来水;(2)甲状腺功能减退组(n = 8)饮用含60毫克/千克甲巯咪唑的水;(3)替代组(n = 8)饮用含60毫克/千克甲巯咪唑加35微克/千克甲状腺激素(T3)的水。治疗四周后,对所有组的大鼠进行断头处死。解剖取出大脑皮层、杏仁核、海马体和小脑,并在-70℃下冷冻保存直至检测。进行酶活性检测时,将组织匀浆。在存在和不存在1毫摩尔哇巴因的情况下,将样品与ATP孵育后,通过定量无机磷酸盐来测定钠钾ATP酶活性。钠钾ATP酶活性以皮摩尔无机磷/小时/毫克蛋白表示。结果显示,甲状腺功能减退组大脑皮层、杏仁核和海马体中的钠钾ATP酶活性低于对照组,但小脑无此差异(p < 0.05)。甲巯咪唑与T3联合给药可避免钠钾ATP酶活性降低,但杏仁核除外。根据所得结果,我们得出结论,甲巯咪唑治疗会降低与癫痫发作起始相关脑区的钠钾ATP酶活性。甲状腺激素联合给药可避免该酶活性的降低。